Navigation Links
Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
Date:2/10/2010

JERUSALEM, February 10 /PRNewswire/ -- The Gamida Cell-Teva Joint Venture (JV) announced today that the Data Monitoring Committee (DMC) has independently reviewed preliminary data from the pivotal registration, Phase III clinical trial of StemEx (called ExCell) and has recommended that the JV continue to enroll patients in this study. The next data analysis is anticipated to take place during Q2 2010. StemEx is being evaluated as a therapeutic treatment for adolescents and adults with blood cancers such as leukemia and lymphoma, who cannot find a family related matched bone marrow donor.

The DMC's primary charge is to ensure that the study is conducted in an ethical manner that does not expose participants to undue risk. In addition, the Committee monitors the quality and overall conduct of the study and assesses whether to recommend that the sponsor modify or terminate an ongoing study, or whether to request further information for review. The DMC for the Phase III StemEx study, comprised of an independent group of medical and scientific experts, reviewed safety and efficacy data from participating sites to assess treatment benefit (or harm) to study participants. The DMC had no safety concerns and recommended that accrual on the study continue.

Dr. Yael Margolin, president and chief executive officer of Gamida Cell said, "This is another important milestone, that the DMC has reviewed the data and recommended continuing the phase III study of StemEx. With this green light, we shall continue enrolling patients in the trial with plans to bring StemEx to the market in 2011. We also hope that today's news will help to increase awareness of StemEx as an investigational treatment amongst patients with leukemia and lymphoma to consider in consultation with their physician."

StemEx is a gra
'/>"/>

SOURCE Gamida Cell Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
2. New Research Gives Insight to the Frequency of Doctor Shopping Occurring Within Prescription Monitoring Programs
3. FDA Awards Contract to Harvard Pilgrim to Develop Pilot for Safety Monitoring System
4. Revolutionary Radiation Monitoring Device for CT Scans
5. Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse
6. ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System
7. Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends
8. Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends
9. Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership
10. Reportlinker Adds Holter Monitoring Systems - A Global Market Review
11. Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015 /PRNewswire/ – Small Cap IR issues ... to supply custom Arrayit blood card technology to Vivos, ... on earth. Vivos offers an impervious, impenetrable and permanent ... woman and child on Earth, a safe and secure ... blood cards allow the rapid collection, separation, drying and ...
(Date:6/30/2015)... 30, 2015  Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and ... results from a Category 3 human abuse ... extended-release, oral oxycodone product candidate in late-stage ... severe enough to require daily, around-the-clock opioid ...
(Date:6/30/2015)... 30, 2015 PharmaVentures is pleased ... Chip-Man Technologies Oy (CMT) on its divestment of certain ... to CMTs world leading capabilities in cellular imaging and ... a series of successful global deals in the life ... Fintan Walton , CEO, PharmaVentures, commented: "PharmaVentures is ...
Breaking Medicine Technology:Small Cap IR - Empowering the Age of Genetic Enlightenment 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5PharmaVentures Completes M&A Deal for Technology in the Stem Cell & Regenerative Medicine Sector 2
... SAN DIEGO, May 5, 2011 /PRNewswire/ -- Halozyme ... developing and commercializing products targeting the extracellular matrix , ... of America Merrill Lynch Health Care Conference in Las Vegas. ... PDT (2:10 p.m. EDT). To listen to the live webcast ...
... 2011 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT ) ... 31, 2011.  Savient ended the quarter with $268.0 million in ... December 31, 2010, primarily due to the issuance and sale ... the first quarter of 2011, the Company had a net ...
Cached Medicine Technology:Halozyme Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference on May 12 2Savient Pharmaceuticals Reports First Quarter 2011 Financial Results 2Savient Pharmaceuticals Reports First Quarter 2011 Financial Results 3Savient Pharmaceuticals Reports First Quarter 2011 Financial Results 4Savient Pharmaceuticals Reports First Quarter 2011 Financial Results 5Savient Pharmaceuticals Reports First Quarter 2011 Financial Results 6Savient Pharmaceuticals Reports First Quarter 2011 Financial Results 7
(Date:7/1/2015)... Las Vegas, NV (PRWEB) , ... July 01, ... ... Foundation will be showcasing the newly launched Patient Self-Management (PSM) Solutions at the ... proven model that has been in use for over 10 years, can reduce ...
(Date:6/30/2015)... ... 2015 , ... Avid boxing style rock concert poster collector, Andrew Hawley from ... The Who and the Rascals also played at this concert in New York City. ... with the Who backing them up. The Doors gave a very stirring performance on ...
(Date:6/30/2015)... ... 2015 , ... Popular review portal HerpesDatingSites.org recently refreshed its ... changes to the UI, the website hopes to benefit more users from across ... has been getting tougher. People are seeking professional assistance while searching for the ...
(Date:6/30/2015)... ... 30, 2015 , ... Ticket Down is a reliable source for cheap tickets for Journey ... This legendary band has been packing venues for years and they are one of the ... 20 albums in their career. While Journey is known for their all-around great sound, ...
(Date:6/30/2015)... ... 2015 , ... The Blue Cross and Blue Shield of Minnesota Foundation today ... The projects improve community health by focusing on the social and economic factors that ... for a second year in 2016 based on progress in 2015. , “We took ...
Breaking Medicine News(10 mins):Health News:APhA Foundation to Showcase Newly Introduced Patient Self-Management Solutions at the Society for Human Resource Management (SHRM) Annual Conference and Exposition 2Health News:Avid Boxing Style Rock Concert Poster Collector From Vintage Rock Posters Announces Search for 1968 Doors and Jimi Hendrix Singer Bowl Concert Posters 2Health News:HerpesDatingSites.org Introduces a New Responsive Design 2Health News:Journey Tickets at The Stadium of Fire at Lavell Edwards Stadium in Provo, Utah: Ticket Down Slashes Ticket Prices for Journey on the 4th of July in Provo 2Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2
... as sex is, perhaps vying with each other for all ... - responsible //for many diseases, failed pregnancy, miscarriage, etc. Recently ... of problems, like ADHD in the child and premature delivery. ... and hormonal cycles. ,Women seem to be twice inclined ...
... say that the antipsychotic drug, clozapine has some very ... drug available. ,"Clozapine is the last hope ... This study suggests that patients who need the most ... place," said J. Steven Lamberti, the lead author of ...
... Paris have concluded that at least one decade is needed ... Dr. David Fedson, former professor// of medicine at the University ... was nothing short of a catastrophe for the public. ... work with for three years and after three years this ...
... some progress has been taken to improve the oral ... be investigated - Researchers team reported// in an international ... countries including Australia, China, Finland, Ireland, Japan, Kuwait, Scotland, ... International Association for Dental Research that more work were ...
... and often the barrier to change is a preoccupation ... Is oatmeal better// than raisin bran? Of course individual ... overall dietary pattern, according to the July issue of ... Harvard’s Health Professionals Follow-up Study examined the effect of ...
... study by the Department of Energy's Pacific Northwest National ... that the damage in neurodegenerative diseases// is linked to ... explained that Parkinson's, Alzheimer's, Lou Gehrig's disease and other ... of problems in health conditions that can be credited ...
Cached Medicine News:Health News:Unhealthy Oral Habits among Teenagers – Reported Dental Health Authoritie 2Health News:Scientist Optimistic In Breakthrough For Causes Of Neurodegenerative Diseases 2
Designed to be removed from under surgical gown without compromising sterile fields. Two straps criss-cross in the back and attach with velcro in the front....
Wolfs unique apron and vest set distributes weight evenly between shoulders and hips. The vest comes with an attached Thyroid collar...
... Full frontal protection, our conventional ... shoulders by sturdy 2 webbed ... quick-acting snap hook fasteners. The ... custom fit the apron. Our ...
... Aprons are the result of a technologically ... x-ray aprons. Constructed with a wear resistant, ... the Lead Free aprons exhibit the same ... Each apron weighs approximately 50% less than ...
Medicine Products: